Company
Last deal
$5.5M
Local Amount - EUR 5.M
Amount
Series A
Stage
14.08.2023
Date
1
all rounds
$5.5M
Total amount
General
About Company
VRG Therapeutics develops miniprotein-based meds and gene therapy to cure untreatable diseases.
Industry
Sector :
Subsector :
Also Known As
VRG Tx, Vascular Research Group
Number of employees
Company Type
For Profit
Last funding type
Series A
IPO status
Private
Contacts
location
Phone number
Website URL